Search

Author/Creator Loaiza, Lazaro

2. Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials. Issue 1 (25th March 2019)

Authors:
Lancaster, Lisa; Crestani, Bruno; Hernandez, Paul; Inoue, Yoshikazu; Wachtlin, Daniel; Loaiza, Lazaro; Quaresma, Manuel; Stowasser, Susanne; Richeldi, Luca
Journal:
BMJ open respiratory research
Issue:
Volume 6:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials. (October 2022)

Authors:
Hoffmann-Vold, Anna-Maria; Volkmann, Elizabeth R; Allanore, Yannick; Assassi, Shervin; de Vries-Bouwstra, Jeska K; Smith, Vanessa; Tschoepe, Inga; Loaiza, Lazaro; Kanakapura, Madhu; Distler, Oliver
Journal:
Lancet
Issue:
Volume 4:Number 10(2022)
Page Start:
e679
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials. (September 2022)

Authors:
Hoffmann-Vold, Anna-Maria; Volkmann, Elizabeth R; Allanore, Yannick; Assassi, Shervin; de Vries-Bouwstra, Jeska K; Smith, Vanessa; Tschoepe, Inga; Loaiza, Lazaro; Kanakapura, Madhu; Distler, Oliver
Journal:
Lancet
Issue:
Volume 4(2022)Supplement 1
Page Start:
S3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗